Table 4: Inclusion and exclusion criteria.
Selection and Exclusion Criteria |
Sample Size |
Excluded |
NCDB Breast PUF Cancer Cases |
2696734 |
- |
Year of diagnosis 2004 ~ 2015 |
1982168 |
714566 |
Include sequence number in 0 or 1 |
1645418 |
336750 |
Exclude cases treatment decision was not done at reporting facility |
1581834 |
63584 |
Include Histology 8500 8501 8503 8522 |
1176472 |
405362 |
Exclude male patients |
1165374 |
11098 |
Exclude tumor behavior as invasive |
157044 |
1008330 |
Include Clinical and Pathological stage 0 |
57329 |
99715 |
Include Diagnostic Confirmation as 1 2 |
57320 |
9 |
Exclude Tumor Invasive Component defined by CS_SITESPECIFIC_FACTOR_6 |
57297 |
23 |
Exclude cases with positive regional nodes |
57297 |
0 |
Exclude cases without surgery at primary site or unknown |
56988 |
309 |
Include Surgical Margin as negative |
54611 |
2377 |
Exclude cases died within 90 day after surgery |
54558 |
53 |
Exclude missing outcome |
53909 |
649 |
Include ERPR as 0 1 |
46641 |
7268 |
Exclude cases with bilateral mastectomy |
34444 |
12197 |
*Sequence number: 0 = only cancer, 1 = first cancer.
*Histology: 8500 = DCIS, 8501 = comedocarcinoma, non infiltrating, 8503 = intraductal papillary adenocarcinoma, non infiltrating, 8522 = DCIS + LCIS.
*CS_SITESPECIFIC_FACTOR_6 = Invasive Component.